| |
PRHK (n = 54)
|
no PRHK (n = 32)
|
P
|
|---|
|
sK+1 (mmol/L)
|
6.36 ± 0.57
|
4.77 ± 0.39
|
< 0.001
|
|
sK+5 (mmol/L)
|
4.20 ± 0.96
|
3.36 ± 0.46
|
< 0.001
|
|
Maximum percentage increase in sK+ after reperfusion (%)
|
51.61 ± 23.62
|
20.27 ± 13.88
|
< 0.001
|
|
Significant arrhythmias (n)
|
36 (66.7%)
|
6 (18.8%)
|
< 0.001
|
|
Cardiac arrest (n)
|
6 (11.1%)
|
1 (3.1%)
|
0.250
|
|
Severe PRS (n)
|
43 (79.6%)
|
18 (56.3%)
|
0.021
|
|
Ventilation time (hours)
|
3.8 (2.7–6.6)
|
4.0 (2.1–5.5)
|
0.834
|
|
Length of ICU stay (days)
|
3.0 (2.5–4.0)
|
3.4 (2.7–4.2)
|
0.444
|
|
Hospitalization time (days)
|
18.5 (15.0–27.0)
|
21.0 (17.0–25.8)
|
0.178
|
|
EAD (n)
|
32 (59.3%)
|
5 (15.6%)
|
< 0.001
|
|
AKI (n)a
|
22 (43.1%)
|
18 (62.1%)
|
0.104
|
|
Re-operation (n)
|
4 (7.4%)
|
4 (12.5%)
|
0.432
|
|
In-hospital mortality (n)
|
2 (3.7%)
|
2 (6.3%)
|
0.626
|
- Data are presented as mean and standard deviation (SD), median (interquartile range), or n (%). AKI acute kidney injury, EAD early allograft dysfunction, ICU intensive care unit, PRHK postreperfusion hyperkalemia, PRS postreperfusion syndrome, sK+ serum potassium concentration, sK+1 serum potassium concentration at one minute following reperfusion, sK+5 serum potassium concentration at five minutes following reperfusion. aPatients with preoperative dialysis or serum creatinine ≥ 133 μmol/L were excluded
